Remeron is a brand name for the antidepressant mirtazapine. It belongs to the class of antidepressants and is available in pill form at strengths of 7.5 mg, 15 mg, and 30 mg. In Hong Kong, Remeron is a prescription-only medication regulated by the Department of Health. The drug is marketed for the treatment of major depressive disorder and is sometimes prescribed off-label for other conditions after clinical evaluation.
Mirtazapine works by modulating the activity of several neurotransmitters that influence mood and anxiety. Its primary actions are:
These combined actions lead to a rapid increase in neurotransmitter signaling that can lift mood, reduce anxiety, and improve sleep. Onset of clinical benefit typically appears within 1-2 weeks, with maximal effect often reached after 4-6 weeks of continuous therapy.
Remeron is approved by regulatory agencies, including Hong Kong’s Department of Health, for the treatment of major depressive disorder (MDD) in adult patients. It is indicated for individuals who require an alternative to selective serotonin reuptake inhibitors (SSRIs) or who have not achieved adequate response with other antidepressants.
Typical patient populations include:
Off-label prescribing of mirtazapine may be considered when clinical evidence supports benefit and the potential risks are managed. The following applications have been explored in peer-reviewed studies:
These uses are not approved by the Hong Kong regulatory authority. Off-label use requires medical supervision and an individualized risk-benefit assessment.
Standard dosing
Initiate most adults at 7.5 mg once daily, preferably in the evening to take advantage of the sedative effect.
If tolerated, increase to 15 mg after 1-2 weeks; further titration to 30 mg may be considered based on clinical response.
Special populations
Elderly - start at 7.5 mg and evaluate after 2 weeks before any increase.
Hepatic impairment - consider starting at 7.5 mg and increase cautiously.
Administration
Swallow the pill whole with water; it can be taken with or without food.
Store at room temperature, away from moisture and heat.
Missed dose
If you miss a dose, take it as soon as you remember unless it is near the time of the next scheduled dose. Do not double the dose.
Overdose
Symptoms may include extreme sedation, respiratory depression, or cardiac instability. Seek emergency medical care immediately; supportive care and monitoring are the mainstays of treatment.
Discontinuation
Do not stop abruptly. Gradual taper (e.g., reduce by 7.5 mg every 1-2 weeks) helps minimize withdrawal symptoms such as insomnia, anxiety, or flu-like sensations.
Regular follow-up with a healthcare provider is essential to ensure therapeutic efficacy and safety.
This article provides educational information about Remeron and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Low-dose mirtazapine (7.5 mg) is sometimes prescribed off-label for primary insomnia because of its strong antihistaminic effect. This use is not approved in Hong Kong, and a physician should evaluate the risks versus benefits before initiating therapy.
Most patients notice sedation or increased sleepiness within the first few days, especially when taken at night. Appetite may also increase, leading to modest weight gain. These effects often lessen after 1-2 weeks as the body adapts.
Unlike selective serotonin reuptake inhibitors, mirtazapine works by blocking α₂-adrenergic receptors and several serotonin subtypes, resulting in a dual mechanism that can be advantageous for patients who do not respond to SSRIs or who need a more sedating profile.
Alcohol can intensify the sedative properties of mirtazapine, increasing the risk of excessive drowsiness, dizziness, and impaired coordination. It is advisable to limit or avoid alcohol, particularly during dose titration.
Mirtazapine more commonly leads to weight gain due to increased appetite and metabolic changes. Weight loss is rare and would typically indicate another underlying issue that should be discussed with a clinician.
Mirtazapine may cause orthostatic hypotension, especially in the elderly or when standing quickly. Patients should rise slowly from sitting or lying positions and report any episodes of dizziness or fainting.
The duration of therapy depends on the severity of depression and response to treatment. Many clinicians recommend continuing the medication for at least 6-12 months after remission to reduce the risk of relapse, with periodic reassessment.
Yes, mirtazapine is also marketed as a generic tablet. The brand name Remeron and the generic version contain the same active ingredient and have comparable efficacy when prescribed at equivalent doses.
Remeron tablets are typically round, white to off-white, and embossed with a dosage-specific code (e.g., “7.5,” “15,” or “30”) followed by the brand logo. Exact imprint details may vary by manufacturer.
When traveling, keep the medication in its original pharmacy-labeled container, carry a copy of the prescription, and be aware of the destination country’s import regulations for prescription drugs. In Hong Kong, a valid prescription from a licensed practitioner is required for customs clearance.
